Eco R1 Capital, LLC Protagonist Therapeutics, Inc Transaction History

Eco R1 Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $25.52 $2.69 Million - $9.74 Million	-381,711 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $52.7 Million - $81.5 Million	-2,257,995 Reduced 85.54%	381,711 $9.04 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $21.1 Million - $44.4 Million	1,195,906 Added 82.83%	2,639,706 $90.3 Million
Q3 2021 Nov 15, 2021	BUY	$12.95 - $49.69 $18.7 Million - $71.7 Million	1,443,800 New	1,443,800 $25.6 Million
Q2 2018 Aug 14, 2018	SELL	$5.99 - $9.1 $6.49 Million - $9.86 Million	-1,083,567 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.46 - $23.08 $9.17 Million - $25 Million	1,083,567 New	1,083,567 $9.31 Million

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.